Tier II Research Chair; CRC in Nucleic Acid Therapeutics & Immune Engineering, Departme

Overview

Tier II Canada Research Chair (CRC) in Nucleic Acid Therapeutics & Immune Engineering, Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary.

Assistant Professor, tenure‑track appointment.

• Develop an independent, externally funded research program in nucleic acid therapeutics and immune engineering.
• Secure peer‑reviewed national and provincial grants.
• Deliver undergraduate and graduate teaching and supervise graduate students.
• Collaborate with members of the Inflammation Research Network, Gastrointestinal Research Group, Immunology Research Group and/or Lung Health Research Group.

• Ph.D. (or equivalent) with at least three years of post‑doctoral experience.
• Track record in nucleic acid therapeutics and immune engineering (publications, external awards, letters of reference).
• Demonstrated ability to lead an independent research program and to secure independent funding.
• Teaching experience and ability to supervise graduate students.
• Emerging scholar: active researcher fewer than ten years at time of nomination.

• Submit online application via the University of Calgary Careers webpage using the “Apply Now” link.
• Maximum of four attachments, organized as follows:

Questions may be directed to Dr. Robert Newton, Head, Department of Physiology & Pharmacology (c/o Neil Chander, ).

• Posting Date:
  December 19, 2025
• Closing Date:
  January 25, 2026

Universal commitment to diversity, equity and inclusion. Applicants from underrepresented groups encouraged. Canadians and permanent residents given priority. Indigenous Strategy “ii’ taa'poh’to'p” implemented campus‑wide.